Neuro-Oncology · 2020 · 20 citations · 29 references
MedicineNeuroscienceOncologyNeuro-oncologyNeurodegenerationRadiobiologyBiological Effects Of RadiationBrain TumorsCentral Nervous System ToxicityGlioma RadiotherapyNeuroprotectionRadiation TherapyMicroglia ActivationNeural Stem Cell Radiation ResponseNeurocognitive PreservationRadiation EffectsRadiation-induced Brain InjuryRadiation-related Cognitive ImpairmentSphere Formation AssaysTreatment-related Neurotoxicity
BACKGROUND: Normal tissue toxicity is an inevitable consequence of primary or secondary brain tumor radiotherapy. Cranial irradiation commonly leads to neurocognitive deficits that manifest months or years after treatment. Mechanistically, radiation-induced loss of neural stem/progenitor cells, neuroinflammation, and demyelination are contributing factors that lead to progressive cognitive decline. METHODS: The effects of 1-[(4-nitrophenyl)sulfonyl]-4-phenylpiperazine (NSPP) on irradiated murine neurospheres, microglia cells, and patient-derived gliomaspheres were assessed by sphere-formation assays, flow cytometry, and interleukin (IL)-6 enzyme-linked immunosorbent assay. Activation of the hedgehog pathway was studied by quantitative reverse transcription PCR. The in vivo effects of NSPP were analyzed using flow cytometry, sphere-formation assays, immunohistochemistry, behavioral testing, and an intracranial mouse model of glioblastoma. RESULTS: We report that NSPP mitigates radiation-induced normal tissue toxicity in the brains of mice. NSPP treatment significantly increased the number of neural stem/progenitor cells after brain irradiation in female animals, and inhibited radiation-induced microglia activation and expression of the pro-inflammatory cytokine IL-6. Behavioral testing revealed that treatment with NSPP after radiotherapy was able to successfully mitigate radiation-induced decline in memory function of the brain. In mouse models of glioblastoma, NSPP showed no toxicity and did not interfere with the growth-delaying effects of radiation. CONCLUSIONS: We conclude that NSPP has the potential to mitigate cognitive decline in patients undergoing partial or whole brain irradiation without promoting tumor growth and that the use of this compound as a radiation mitigator of radiation late effects on the central nervous system warrants further investigation.
29
Vinai Gondi, Stephanie L. Pugh, Wolfgang A. Tomé et al. · Journal of Clinical Oncology · 2014 · 1.1K citations · Full text
Eveline Gart, Everton Souto Lima, Frank Schuren et al. · International Journal of Molecular Sciences · 2018 · 1.1K citations · Full text
Small molecule modulation of Smoothened activity
James Chen, Jussi Taipale, Keith E. Young et al. · Proceedings of the National Academy of Sciences · 2002 · 996 citations
Paul D. Brown, S. Pugh, Nadia N. Laack et al. · Neuro-Oncology · 2013 · 944 citations · Full text